[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-1-en-105":3,"doc-seo-564660-105":53,"doc-detail-564660-en":127},{"code":4,"msg":5,"data":6},0,"success",[7,14,19,24,29,34,39,44,49],{"id":8,"doc_module":9,"doc_module_name":10,"category_name":11,"show_sort_weight":12,"slug":13},11,1,"Template","Presentations",90,"presentations",{"id":15,"doc_module":9,"doc_module_name":10,"category_name":16,"show_sort_weight":17,"slug":18},12,"Resumes",80,"resumes",{"id":20,"doc_module":9,"doc_module_name":10,"category_name":21,"show_sort_weight":22,"slug":23},14,"Invoices",70,"invoices",{"id":25,"doc_module":9,"doc_module_name":10,"category_name":26,"show_sort_weight":27,"slug":28},15,"Posters",60,"posters",{"id":30,"doc_module":9,"doc_module_name":10,"category_name":31,"show_sort_weight":32,"slug":33},16,"Social Media",50,"social-media",{"id":35,"doc_module":9,"doc_module_name":10,"category_name":36,"show_sort_weight":37,"slug":38},17,"Forms",40,"forms",{"id":40,"doc_module":9,"doc_module_name":10,"category_name":41,"show_sort_weight":42,"slug":43},18,"Letters",30,"letters",{"id":45,"doc_module":9,"doc_module_name":10,"category_name":46,"show_sort_weight":47,"slug":48},21,"Paper Templates",5,"papers-templates",{"id":50,"doc_module":9,"doc_module_name":10,"category_name":51,"show_sort_weight":4,"slug":52},158,"General","general-158",{"code":4,"msg":54,"data":55},"ok",{"site_id":56,"language":57,"slug":58,"title":59,"keywords":60,"description":61,"schema_data":62,"social_meta":120,"head_meta":122,"extra_data":124,"updated_unix":126},105,"en","adhd-medication-table-methylphenidate-formulations","ADHD Medication Table - METHYLPHENIDATE Formulations","","ADHD Medication Table provides a structured reference for stimulant treatment using methylphenidate-based formulations for attention-deficit/hyperactivity disorders. It lists common products and available strengths, then summarizes dosing initiation and titration schedules, daily dose ranges, and expected onset and duration for immediate and extended-release forms. It also highlights key safety considerations, potential side effects, crushing or opening guidance for specific formulations, monitoring needs, and cautions related to appetite, sleep, cardiovascular history, and growth.",{"@graph":63,"@context":119},[64,80,102],{"@type":65,"itemListElement":66},"BreadcrumbList",[67,71,74,77],{"item":68,"name":69,"@type":70,"position":9},"https://docshare.wps.com","Home","ListItem",{"item":72,"name":10,"@type":70,"position":73},"https://docshare.wps.com/template/",2,{"item":75,"name":51,"@type":70,"position":76},"https://docshare.wps.com/template/general/",3,{"item":78,"name":59,"@type":70,"position":79},"https://docshare.wps.com/template/adhd-medication-table-methylphenidate-formulations/564660/",4,{"url":78,"name":59,"@type":81,"image":82,"author":87,"headline":59,"publisher":90,"fileFormat":93,"inLanguage":57,"description":61,"dateModified":94,"datePublished":95,"encodingFormat":93,"isAccessibleForFree":96,"interactionStatistic":97},"DigitalDocument",{"url":83,"@type":84,"width":85,"height":86},"https://docshare.wps.com/thumbnails/adhd-medication-table-methylphenidate-formulations/564660.png","ImageObject",442,249,{"name":88,"@type":89},"RuangKosong","Person",{"url":68,"name":91,"@type":92},"DocShare","Organization","application/pdf","2026-10-24","2026-10-12",true,{"@type":98,"interactionType":99,"userInteractionCount":101},"InteractionCounter",{"@type":100},"ViewAction",8,{"@type":103,"mainEntity":104},"FAQPage",[105,111,115],{"name":106,"@type":107,"acceptedAnswer":108},"What dosing schedule is recommended to start methylphenidate preparations, and how is it increased?","Question",{"text":109,"@type":110},"Most listed methylphenidate options start at a low initial dose (often 5 mg or 0.3 mg/kg/dose for immediate release), then increase in weekly steps (commonly 2.5 mg to 5 mg weekly). Several extended-release products specify weekly or every-other-week adjustments while keeping once-daily morning administration.","Answer",{"name":112,"@type":107,"acceptedAnswer":113},"How long do immediate-release versus extended-release methylphenidate formulations typically last?",{"text":114,"@type":110},"Immediate-release forms generally onset in about 15–30 minutes and last about 3–5 hours. Extended-release products commonly start around 30–60 minutes and last roughly 8–12 hours, with specific ratios of immediate-release versus extended-release components depending on the formulation.",{"name":116,"@type":107,"acceptedAnswer":117},"What monitoring and major caution items are emphasized for these medications?",{"text":118,"@type":110},"The table stresses reviewing and documenting personal and family cardiac history, and monitoring height, weight, blood pressure, and pulse. It also lists common side effects such as anorexia, insomnia, stomachaches, headaches, irritability, rebound effects, and, more rarely, neuropsychiatric events; it recommends caution and ongoing documentation of symptoms and tolerability.","https://schema.org",{"og:url":78,"og:type":121,"og:title":59,"og:site_name":91,"og:description":61},"article",{"robots":123,"canonical":78},"index,follow",{"doc_id":125,"site_id":56},564660,1792086355,{"code":4,"msg":5,"data":128},{"doc_id":125,"user_id":129,"nickname":88,"user_avatar":130,"doc_module":9,"category_id":50,"category_name":51,"doc_title":59,"doc_description":61,"doc_content":131,"file_id":132,"file_url":133,"file_type":134,"file_size":135,"view_count":101,"is_deleted":4,"is_public":9,"is_downloadable":9,"audit_status":9,"page_count":47,"language":136,"language_code":57,"site_id":56,"html_lang":57,"table_of_contents":137,"faqs":138,"seo_title":139,"seo_description":61,"update_tm":140,"read_time":73},962090883219,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","ADHD Medication Table  \nTable A: METHYLPHENIDATE Formulations: Stimulant Medications for Attention-Deficit/Hyperactivity Disorders Immediate Release  \nP= personal  \n\n| Medication | Dose Schedule | Range | Onset Duration | Potential Side Effects/Cautions |\n| --- | --- | --- | --- | --- |\n| Ritalin ®\u003Cbr>Methylphenidate (MPH)\u003Cbr>5, 10, 20 mg tablets\u003Cbr>Generic available | Initial: 5 mg or 0.3 mg/kg/dose *\u003Cbr>Increase: 2.5 mg-5 mg weekly.\u003Cbr>Frequency: 2 to 3 doses/day. rarely qid.\u003Cbr>*Not weight dependent.\u003Cbr>start low increase weekly to find best dose | 6 yr. + but studied\u003Cbr>in preschoolers\u003Cbr>5-60 mg/day\u003Cbr>Off label: >50 kg\u003Cbr>max 100mg/day | Onset: 15-20min. Short acting Duration: 3-5 hr. | -can be crushed in applesauce (P)\u003Cbr>-Anorexia, insomnia, stomachaches, headaches, irritability, \"rebound\", flattened affect, social withdrawal, weepiness, tics, growth suppression, rare-neuropsychiatric (hallucination), tachycardia\u003Cbr>-Not contraindicated with tics-most improve.\u003Cbr>-review and document personal and family cardiac history\u003Cbr>-Monitor height, weight, blood pressure and pulse. |\n| Methylin Chewable® (grape)\u003Cbr>2.5, 5, 10 mg\u003Cbr>Methylin Solution (grape) *\u003Cbr>5 mg/5ml; 10 mg/5 ml | Initial: 5 mg or 0.3 mg/kg/dose\u003Cbr>Increase: 2.5 mg-5 mg weekly.\u003Cbr>Frequency: 2 to 3 doses/day. rarely qid. | 6 yr. +\u003Cbr>5-60 mg/day | Onset: 20-30 min. Short acting Duration: 3-5 hr. | -chewable tablets/liquid\u003Cbr>-Same side effect profile and precautions as methylphenidate\u003Cbr>-now available as generic (Gavis) |\n| Dexmethylphenidate\u003Cbr>Focalin ®\u003Cbr>2.5, 5, 10 mg tablets\u003Cbr>Generic available | 2.5 mg Focalin ~ equivalent 5 mg MPH Initial: 2.5 in AM\u003Cbr>Increase: weekly or every other week\u003Cbr>Frequency: 2 to 3 doses/day. | 6 yr. +\u003Cbr>5-20 mg/day | Onset: 20-30 min. Short to Intermediate Duration: 5 hr. | -can be crushed in applesauce (P)\u003Cbr>-reported to have lower rate of side effects (e.g. anorexia)\u003Cbr>-Same side effect profile and precautions as methylphenidate |\n| Methylphenidate Extended Release |  |  |  |  |\n| Ritalin LA ®\u003Cbr>10, 20, 30, 40 mg capsules | Initial: 10 mg in AM\u003Cbr>Increase: weekly or every other week\u003Cbr>Frequency: once daily in AM | 6 yr. +\u003Cbr>10-60 mg/day | Onset:30 min\u003Cbr>Duration: 8 hours\u003Cbr>-50% IR, 50% DR beads | -can be opened and sprinkled; do not chew beads\u003Cbr>-Same side effect profile and precautions as methylphenidate |\n| Metadate CD ®\u003Cbr>10, 20, 30, 40, 50, 60 mg capsules | Initial: 10 mg in AM\u003Cbr>Increase: weekly or every other week\u003Cbr>Frequency: once daily in AM | 6 yr. +\u003Cbr>10-60 mg/day | Onset:30 min\u003Cbr>Duration: 8 hours 30% IR, 70% ER | -can be opened and sprinkled; do not chew beads\u003Cbr>-Same side effect profile and precautions as methylphenidate |\n| Concerta ®\u003Cbr>18, 27, 36, 54 mg OROS capsule Many Generic available | 18 mg delivers equivalent of 5 mg TID Initial: 18 mg in AM\u003Cbr>Increase: weekly or every other week\u003Cbr>Frequency: once daily in AM | 6 yr. +\u003Cbr>18 to 72 mg\u003Cbr>72 mg (36 +36) | Onset:45-60 min Long acting Duration: 10-12 hrs.\u003Cbr>22%IR, 78%osmotic release | -capsule cannot be opened, swallow whole,\u003Cbr>-Same side effect profile and precautions as methylphenidate\u003Cbr>-non-absorbable capsule shell may be seen in stool\u003Cbr>22%IR, 78% ER\u003Cbr>Variability in Generics |\n| Aptensio XR ®\u003Cbr>10, 15, 20, 30, 40, 50, and 60 mg. | Initial: 10 mg\u003Cbr>Increase: weekly or every other week\u003Cbr>Frequency: once daily in AM | 6 yr. +\u003Cbr>10-60 mg/day | Onset:45-60 min\u003Cbr>Duration: 12 hrs. 37%IR, 63% ER | -can be opened and sprinkled; do not chew beads\u003Cbr>~ 60 percent is delivered slowly through the rest of the day.\u003Cbr>~two medication “peaks” -at two hours and another at eight hours. |\n| Adhansia XR® 25.35,45,55,70,85mg | 25mg | 6 yr. + 25-70mg\u003Cbr>Adults 80mg max | 12-hour duration Biphasic 20%IR,80%ER | Cn open ans sprinkle applesauce or yogurt |\n| QuillivantXR Liquid Suspension (25mg/5 ML) ® | Initial: 2 ML in AM (10 mg)\u003Cbr>Increase: weekly or every other week | 6 yr. +\u003Cbr>10-50 mg/day | Onset: 45 min; Duration 8-12 hrs. 20% IR, ","cbCaitgvW6vCacBu","https://ap.wps.com/l/cbCaitgvW6vCacBu","pdf",294343,"English","# ADHD Medication Table\n## METHYLPHENIDATE Formulations\n## Immediate-Release Options\n## Extended-Release Options\n## Side Effects and Monitoring","[{\"question\":\"What dosing schedule is recommended to start methylphenidate preparations, and how is it increased?\",\"answer\":\"Most listed methylphenidate options start at a low initial dose (often 5 mg or 0.3 mg/kg/dose for immediate release), then increase in weekly steps (commonly 2.5 mg to 5 mg weekly). Several extended-release products specify weekly or every-other-week adjustments while keeping once-daily morning administration.\"},{\"question\":\"How long do immediate-release versus extended-release methylphenidate formulations typically last?\",\"answer\":\"Immediate-release forms generally onset in about 15–30 minutes and last about 3–5 hours. Extended-release products commonly start around 30–60 minutes and last roughly 8–12 hours, with specific ratios of immediate-release versus extended-release components depending on the formulation.\"},{\"question\":\"What monitoring and major caution items are emphasized for these medications?\",\"answer\":\"The table stresses reviewing and documenting personal and family cardiac history, and monitoring height, weight, blood pressure, and pulse. It also lists common side effects such as anorexia, insomnia, stomachaches, headaches, irritability, rebound effects, and, more rarely, neuropsychiatric events; it recommends caution and ongoing documentation of symptoms and tolerability.\"}]","ADHD Medication Table - METHYLPHENIDATE Formulations | PDF",1791843570]